Therapeutic Targets for Rare Diseases

Outline an end-to-end translational pathway for identifying and validating novel therapeutic targets for rare genetic diseases. Include target prioritization, preclinical models, biomarker strategies, clinical trial design, regulatory planning, and pathways for patient access and affordability, with risk mitigation and stakeholder collaboration.